Beauty Farm Medical and Health Industry Inc. submitted a Next Day Disclosure Return to the Hong Kong Stock Exchange on 15 April 2026, reporting a fresh tranche of on-market share repurchases executed the same day.

The company acquired 38,000 ordinary shares at prices ranging from HKD 20.36 to HKD 20.58, for a total consideration of HKD 0.78 million and a volume-weighted average price of HKD 20.48.

Following the transaction, the number of issued shares (excluding treasury shares) fell to 250.10 million from 250.14 million, a marginal decrease of 0.02%. Treasury shares increased to 1.50 million, while total issued shares remained unchanged at 251.59 million because the repurchased shares are being held in treasury rather than cancelled.

Since the current repurchase mandate was approved on 27 June 2025, Beauty Farm has bought back 1.50 million shares—0.63% of the 235.80 million shares outstanding at the mandate date—leaving authority to repurchase up to a further 22.08 million shares.

Under Main Board Rule 10.06(3)(a), the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 15 May 2026.